Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind cross-over study of topical PSD503 in female patients with stress urinary incontinence
2005-003572-38Phase 2Terminated
- Sponsor
- Plethora Solutions
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of phenylephrine in stress urinary incontinence (SUI) (2 arms), sponsored by Plethora Solutions. Started Aug 2005; status: terminated.
02
Drugs
phenylephrine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on 2005-003572-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003572-38.